ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 11, 2019 to file lead plaintiff applications in a securities class action lawsuit against AxoGen, Inc. (NasdaqCM: AXGN), if they purchased the Companys securities in connection with its November 2017 or May 2018 secondary public offering or between August 7, 2017 and December 18, 2018, inclusive (the Class Period). This action is pending in the United States District Court for the Middle District of Florida.
AxoGen investors should visit us at https://www.claimsfiler.com/cases/view-axogen-inc-securities-litigation or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
About the Lawsuit
AxoGen and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On December 18, 2018, Seligman Investments reported that former AxoGen employees had made allegations that the Company had engaged in channel stuffing and backdating of revenue as well as the use of misleading operating metrics¦that the companys definition of ˜active accounts may overstate the actual number by a factor of ten.
On this news, AxoGens stock plummeted nearly 22%.
The case is Einhorn v. AxoGen, Inc. et al, 19-cv-00069.
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
Lewis Kahn, 844-367-9658